News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Zeng Ling
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/02/2023 |
4
| Zeng Ling (See Remarks) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 55,000 options to buy
@ $6.46, valued at
$355.3k
|
|
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2022 |
4
| Zeng Ling (See Remarks) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 270,000 options to buy
@ $6.24, valued at
$1.7M
|
|
| 04/01/2022 |
3
| Zeng Ling (See Remarks) has filed a Form 3 on Omega Therapeutics, Inc. |
| 12/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2020 |
4
| Zeng Ling (Chief Legal Officer & Sec'y) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 18,225 restricted stock units
@ $0
Granted 81,825 options to buy
@ $18.69, valued at
$1.5M
|
|
| 09/16/2020 |
3
| Zeng Ling (Chief Legal Officer & Sec'y) has filed a Form 3 on Dicerna Pharmaceuticals Inc |
|
|